LindaFayCarpenterMDMD(She/Her)

Psychopharmacology

Professor, Psychiatry, Warren Alpert Medical School of Brown University

Dr. Carpenter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
345 Blackstone Blvd
Providence, RI 02906
Phone+1 401-455-6200

Fax+1 401-455-6309

Eszopiclone Treatment & Cortisol Responsivity Start of enrollment: 2007 May 01
Completed
Phase 4
Testosterone Antidepressant Augmentation in Women Start of enrollment: 2013 Aug 01
Completed
Not Applicable
Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression Start of enrollment: 2013 Sep 12
Terminated
Phase 2
Brain Connectivity in Depression Start of enrollment: 2018 Apr 03
Recruiting
Not Applicable
Roles: Contact
EMA-Guided Maintenance TMS for Depression Start of enrollment: 2023 Sep 25
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
Join now to see all

PubMed

Neurolief Presents Groundbreaking Study Results of Its Proliv™Rx Brain Neuromodulation Therapy for Treating Major Depression at the 7th Annual Neuropsychiatric Drug SummitOctober 8th, 2024
Jolting the Brain’s Circuits with Electricity Is Moving from Radical to Almost Mainstream Therapy. Some Crucial Hurdles RemainJanuary 12th, 2022
What Is TMS Treatment for Depression?January 5th, 2022
Join now to see all